Getting over addiction to opiates often requires addicts to adhere to medication therapy, but patients sometimes don’t take their medication or take it incorrectly or, worst of all, they sell it to others. This means, obviously, that recovering addicts don’t benefit from this medication therapy as much as they should.
That’s where AiCure comes in.
The company has created an app using advanced facial recognition and motion-sensing technology that can detect, in real time, whether a person is taking their medication as prescribed without the need for human supervision. Patients who take incorrect doses or do not use the software are automatically flagged for immediate follow-up.
The National Institute on Drug Abuse (NIDA) has provided $1 million in funding to assess whether patients using the AiCure platform are more adherent to their medication therapy and whether adoption of the system can improve treatment duration and reduce the risk of relapse.
The trial is being carried out with the Cincinnati Addiction Research Center (CinARC) at the University of Cincinnati and includes a total of 130 participants over the course of 12 months.
Preliminary results of the trial are expected to be published in August 2015.